购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Anti-HVEM Antibody-APC (8R903)

Rating icon 还可以
产品编号 TMAY-00635A

Anti-HVEM Antibody-APC (8R903) 是一种 APC-conjugated Rabbit 抗体,靶向 HVEM。Anti-HVEM Antibody-APC (8R903) 可用于 FCM。

Anti-HVEM Antibody-APC (8R903)

Anti-HVEM Antibody-APC (8R903)

Rating icon 还可以
产品编号 TMAY-00635A

Anti-HVEM Antibody-APC (8R903) 是一种 APC-conjugated Rabbit 抗体,靶向 HVEM。Anti-HVEM Antibody-APC (8R903) 可用于 FCM。

TargetMol
产品信息正在更新中,如果您想购买,请点击大包装&定制按钮.
大包装 & 定制
实验操作小课堂
常见问题解答
查看更多
联系我们获取更多批次信息
资源下载

产品介绍

生物活性
产品描述
Anti-HVEM Antibody-APC (8R903) is a APC-conjugated Rabbit antibody targeting HVEM. Anti-HVEM Antibody-APC (8R903) can be used in FCM.
Ig Type
Monoclonal Rabbit IgG
克隆号
8R903
交叉反应
Human
验证活性
Flow cytometric analysis of Human HVEM(CD270) expression on human whole blood lymphocytes. Cells were stained with APC-conjugated anti-Human HVEM(CD270). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes.
应用
FCM
推荐剂量
5 μl/Test, 0.1 mg/ml
抗体种类
Monoclonal
宿主来源Rabbit
构建方式This antibody was obtained from a rabbit immunized with purified, recombinant Human HVEM/TNFRSF14/CD270 (rh HVEM/TNFRSF14/CD270; TMPY-01750; NP_003811.2; Met1-Val202) and conjugated with APC under optimum conditions, the unreacted APC was removed.
纯化方式Protein A
性状Liquid
缓冲液PBS solution containing 0.5% BSA and 0.09% sodium azide
研究背景Herpesvirus entry mediator (HVEM), also referred to as TNFRSF14, TR2 (TNF receptor-like molecule) and ATAR (another TRAF-associated receptor), is a member of type I transmembrane protein belonging to the TNF-receptor superfamily. It is expressed on many immune cells, including T and B cells, NK cells, monocytes, and neutrophils. Two TNF superfamily ligands lymphotoxin α (TNF-β) and LIGHT (TNFSF14) are identified as cellular ligands for HVEM and initiate the positive signaling. However, recent studies have revealed that HVEM is also involved in the unique inhibitory signaling pathway for T cells through activating tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif (ITIM) in B and T lymphocyte attenuator (BTLA). HVEM provides a stimulatory signal following engagement with LIGHT (TNFSF14) on T cells. In contrast, it can also provide an inhibitory signal to T cells when it binds the B and T lymphocyte attenuator (BTLA), a ligand member of the Immunoglobulin (Ig) superfamily. Thus, HVEM may be viewed as a molecular switch, capable of facilitating both stimulatory and inhibitory cosignaling in T cells. Substantial evidence from both human disease and from experimental mouse models has indicated that dysregulation of the LIGHT-HVEM-BTLA cosignaling pathway can cause inflammation in the lung and in mucosal tissues.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy
偶联与修饰
偶联
APC
其他可选修饰符
Unconjugated/FITC/PE
可提供抗体种类
4
抗原信息
免疫原
Recombinant Human HVEM/TNFRSF14/CD270 Protein (TMPY-01750)
抗原种属
Human
研究领域
Cancer Drug Targets
存储&运输
储存方式Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
运输方式Shipping with blue ice.

SCI 文献

计算器

  • 稀释 计算器

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Anti-HVEM Antibody-APC (8R903) | purchase Anti-HVEM Antibody-APC (8R903) | Anti-HVEM Antibody-APC (8R903) cost | order Anti-HVEM Antibody-APC (8R903)